Truist Financial Corp Has $87.26 Million Stake in Danaher Co. (NYSE:DHR)

Truist Financial Corp lowered its stake in Danaher Co. (NYSE:DHR) by 3.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 380,121 shares of the conglomerate’s stock after selling 12,321 shares during the period. Truist Financial Corp owned approximately 0.05% of Danaher worth $87,257,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Heck Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC bought a new position in Danaher in the 4th quarter worth $31,000. Strategic Financial Concepts LLC bought a new position in Danaher in the 4th quarter worth $31,000. Finally, Pineridge Advisors LLC lifted its position in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Scotiabank assumed coverage on Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. Barclays cut their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Stephens reissued an “overweight” rating and issued a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Finally, UBS Group dropped their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Stock Up 1.5 %

Shares of NYSE:DHR opened at $206.66 on Tuesday. The company’s fifty day moving average is $229.53 and its 200-day moving average is $249.13. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The company has a market capitalization of $149.26 billion, a PE ratio of 39.14, a P/E/G ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 EPS. Equities research analysts predict that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.52%. Danaher’s payout ratio is 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.